Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision oncology's translation gap-Can molecular tumor boards bridge it?

PLoS medicine·2026
Same author

A case report of acute carcinoid heart failure during lutetium-177 dotatate-triapine treatment for well-differentiated neuroendocrine tumors.

Frontiers in oncology·2026
Same author

DENND5B disruption results in reduced body fat and increased intestinal fatty acid oxidation by activation of autophagy.

Journal of lipid research·2026
Same author

Fixed-Bed Bioreactor Culture Enhances Yield and Reparative Properties of hTERT Mesenchymal Stem Cell Extracellular Vesicles.

Cells·2026
Same author

A Phase 1 Dose Escalation of Lapatinib and Paclitaxel in Recurrent Ovarian Cancer.

Cancers·2026
Same author

Inhibition of fatty acid synthase enhances therapeutic efficacy and delays acquired resistance to BRAF-targeted therapy in colorectal cancer.

Neoplasia (New York, N.Y.)·2026

Related Experiment Video

Updated: Jul 25, 2025

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

5.5K

Programming Cell-Derived Vesicles with Enhanced Immunomodulatory Properties.

Khaga R Neupane1, Geraldine S Ramon2, Brock Harvey1

  • 1Department of Chemistry, University of Kentucky, 506 Library Drive, 125 Chemistry-Physics Building, Lexington, KY, 40506, USA.

Advanced Healthcare Materials
|June 28, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces programmed nanovesicles to reprogram tumor-associated macrophages (TAMs) from a pro-tumoral M2 state to an anti-tumoral M1 state, offering a novel cancer immunotherapy strategy.

Keywords:
cancer immunotherapymacrophagespolarizationsignalingvesicles

More Related Videos

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
10:09

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

6.9K
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.3K

Related Experiment Videos

Last Updated: Jul 25, 2025

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

5.5K
Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
10:09

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

6.9K
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.3K

Area of Science:

  • Immunology
  • Nanotechnology
  • Cancer Biology

Background:

  • Tumor-associated macrophages (TAMs) dominate the tumor microenvironment, typically displaying a pro-tumoral M2 phenotype.
  • Macrophage polarization is reversible, offering therapeutic potential by shifting them to an anti-tumoral M1 phenotype.

Purpose of the Study:

  • To develop programmed nanovesicles as an immunomodulatory platform for cancer therapy.
  • To re-polarize M2 macrophages toward a pro-inflammatory M1 phenotype within the tumor microenvironment.

Main Methods:

  • Engineered cellular membrane-derived nanovesicles with specific immunomodulatory properties.
  • Decorated nanovesicles with membrane-bound ligands for targeted delivery to immune cells.
  • Utilized macrophage-derived vesicles to enhance immune cell reprogramming.

Main Results:

  • Demonstrated the capability of programmed nanovesicles to re-polarize M2 macrophages.
  • Showcased bidirectional immune cell polarization modulation.
  • Enhanced reprogramming of immune cells toward a pro-inflammatory phenotype.

Conclusions:

  • Programmed nanovesicles represent a promising therapeutic platform for cancer immunotherapy.
  • Targeted modulation of macrophage phenotype can reverse pro-tumoral functions.
  • This approach offers a novel strategy to enhance anti-tumor immunity.